Live
Endpoints NewsChina’s drugmakers to take the stage at #ASCO26BioPharma DiveBioMarin notches win in study that could expand use of top-selling medicineFierceBiotechLilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profileFierceBiotechBetting on biotech: Prediction markets set sights on clinical trialsEndpoints NewsBioMarin to seek further approval of Voxzogo in form of short statureEndpoints NewsIncyte signs AI deals with Genesis Molecular AI, Edison ScientificBioWorldSizing up an epidemic, with diagnostics and bioinformaticsBioPharma DiveLilly’s triple-acting obesity drug hits goal in Phase 3 trialEndpoints NewsBMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campusBioPharma DiveIn Alzheimer’s, Bristol Myers sees big promise beyond amyloidBioWorldGertrude Biomedical discovers new SOX18 inhibitorsBioWorldHansoh identifies new PI3Kα mutant inhibitors

Archive

Total 11715
Page 549 / 651
Query --